Article No
CDX-C0260-M050
CAS No | 23465-76-1 |
MW | 365.47 |
Article No | CDX-C0260-M050 |
Country Availability | SE, FI, DK, NO, IS, EE, LV, LT |
Description | Caroverin |
Supplier | Adipogen Life Sciences |
Format | Powder |
Notes | Chemical. CAS: 23465-76-1. Formula: C22H27N3O2. MW: 365.47. Synthetic. Quinoxaline compound, originally developed as a spasmolytic drug. Acts as an N-type calcium channel blocker, competitive AMPA receptor antagonist, and non-competitive NMDA receptor antagonist. Antioxidant agent through partial prevention of the formation and the highly active scavenging of hydroxyl radicals. Used to treat inner ear diseases such as tinnitus. Shown to inhibit tumor-promoting factors and potentially useful as a chemotherapeutic agent.|Quinoxaline compound, originally developed as a spasmolytic drug. Acts as an N-type calcium channel blocker, competitive AMPA receptor antagonist, and non-competitive NMDA receptor antagonist. Antioxidant agent through partial prevention of the formation and the highly active scavenging of hydroxyl radicals. Used to treat inner ear diseases such as tinnitus. Shown to inhibit tumor-promoting factors and potentially useful as a chemotherapeutic agent. |
Molecular Formula | C22H27N3O2 |
Alias Names | 1-[2-(Diethylamino)ethyl]-3-(p-methoxybenzyl)-2-quinoxalone; Spadon; Spasmium |
Product Type | Chemicals & Biochemicals |
Purity | >99% |
Research Area | Inflammation |
Shipping Information | RT |
Size | 50 mg |
Solubility | Soluble in DMSO (10 mg/ml). Insolube in water. |
Stability | Stable for at least 2 years after receipt when stored at +4°C. |
Storage | 4°C, RT |
Technical Specifications | Chemical. CAS: 23465-76-1. Formula: C22H27N3O2. MW: 365.47. Synthetic. Quinoxaline compound, originally developed as a spasmolytic drug. Acts as an N-type calcium channel blocker, competitive AMPA receptor antagonist, and non-competitive NMDA receptor antagonist. Antioxidant agent through partial prevention of the formation and the highly active scavenging of hydroxyl radicals. Used to treat inner ear diseases such as tinnitus. Shown to inhibit tumor-promoting factors and potentially useful as a chemotherapeutic agent. |
Product Page Updated | 2024-02-01T08:25:01.492Z |